Endothelial dysfunction and vascular disease–a 30th anniversary update
PM Vanhoutte, H Shimokawa, M Feletou… - Acta …, 2017 - Wiley Online Library
The endothelium can evoke relaxations of the underlying vascular smooth muscle, by
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …
HO-1 overexpression and underexpression: Clinical implications
GS Drummond, J Baum, M Greenberg, D Lewis… - Archives of biochemistry …, 2019 - Elsevier
In this review we examine the effects of both over-and under-production of heme oxygenase-
1 (HO-1) and HO activity on a broad spectrum of biological systems and on vascular …
1 (HO-1) and HO activity on a broad spectrum of biological systems and on vascular …
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
AL Lazaar, L Yang, RL Boardley… - British journal of …, 2016 - Wiley Online Library
Aims Endothelial‐derived epoxyeicosatrienoic acids may regulate vascular tone and are
metabolized by soluble epoxide hydrolase enzymes (sEH). GSK2256294 is a potent and …
metabolized by soluble epoxide hydrolase enzymes (sEH). GSK2256294 is a potent and …
[HTML][HTML] Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: antioxidant action of butyrate
Short chain fatty acids (SCFAs), a family of gut microbial metabolites, have been reported to
promote preservation of endothelial function and thereby exert anti-atherosclerotic action …
promote preservation of endothelial function and thereby exert anti-atherosclerotic action …
Translational significance of heme oxygenase in obesity and metabolic syndrome
NG Abraham, JM Junge, GS Drummond - Trends in pharmacological …, 2016 - cell.com
The global epidemic of obesity continues unabated with sequelae of diabetes and metabolic
syndrome. This review reflects the dramatic increase in research on the role of increased …
syndrome. This review reflects the dramatic increase in research on the role of increased …
PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid
Background/objectives Obesity is a risk factor in the development of type 2 diabetes mellitus
(DM2), which is associated with increased morbidity and mortality, predominantly as a result …
(DM2), which is associated with increased morbidity and mortality, predominantly as a result …
Regulation of CYP2J2 and EET levels in cardiac disease and diabetes
T Aliwarga, EA Evangelista, N Sotoodehnia… - International journal of …, 2018 - mdpi.com
Cytochrome P450 2J2 (CYP2J2) is a known arachidonic acid (AA) epoxygenase that
mediates the formation of four bioactive regioisomers of cis-epoxyeicosatrienoic acids …
mediates the formation of four bioactive regioisomers of cis-epoxyeicosatrienoic acids …
Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1α activation, which is required for HO-1 expression and increased …
Epoxyeicosatrienoic acid (EET) contributes to browning of white adipose stem cells to
ameliorate obesity/diabetes and insulin resistance. In the current study, we show that EET …
ameliorate obesity/diabetes and insulin resistance. In the current study, we show that EET …
Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1/AMPK/PGC-1α pathway
Vasculopathy is a major complication of diabetes. Impaired mitochondrial bioenergetics and
biogenesis due to oxidative stress are a critical causal factor for diabetic endothelial …
biogenesis due to oxidative stress are a critical causal factor for diabetic endothelial …
Fructose mediated non-alcoholic fatty liver is attenuated by HO-1-SIRT1 module in murine hepatocytes and mice fed a high fructose diet
K Sodhi, N Puri, G Favero, S Stevens, C Meadows… - PloS one, 2015 - journals.plos.org
Background Oxidative stress underlies the etiopathogenesis of nonalcoholic fatty liver
disease (NAFLD), obesity and cardiovascular disease (CVD). Heme Oxygenase-1 (HO-1) is …
disease (NAFLD), obesity and cardiovascular disease (CVD). Heme Oxygenase-1 (HO-1) is …